- Filed
- Mar 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 20, 2025 | 18.38M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 18.23M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2023 | $1.46M |
| Capex | FY 2024 · Dec 31, 2023 | $212K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | $16.27M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $1.97B |
| Total Assets | FY 2024 · Dec 31, 2023 | $2.19B |
| Eps Diluted | FY 2024 · Dec 31, 2023 | $0.21 |
| Eps Basic | FY 2024 · Dec 31, 2023 | $0.22 |
| Net Income | FY 2024 · Dec 31, 2023 | $3.82M |
| Revenue | FY 2024 · Dec 31, 2023 | $1.47M |
| Cash And Equivalents | FY 2024 · Dec 31, 2022 | $7.25M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $202.38M |